中文名称: | Soraprazan | ||||
---|---|---|---|---|---|
英文名称: | Soraprazan | ||||
别名: | Soraprazan BYK61359 | ||||
CAS No: | 261944-46-1 | 分子式: | C21H25N3O3 | 分子量: | 367.44 |
CAS No: | 261944-46-1 | ||||
分子式: | C21H25N3O3 | ||||
分子量: | 367.44 |
基本信息
产品编号: |
S10983 |
||||
产品名称: |
Soraprazan |
||||
CAS: |
261944-46-1 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
367.44 |
-20℃ |
1个月 |
||
化学名: |
|||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
|
|||
Ethanol |
|
||||
Water |
|
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.7215mL |
13.6077mL |
27.2153mL |
5mM |
0.5443mL |
2.7215mL |
5.4431mL |
10mM |
0.2722mL |
1.3608mL |
2.7215mL |
生物活性
产品描述 |
一种选择性的钾通道竞争性的H,K-ATPase(Ki=6.4nM)的抑制剂 |
靶点 |
Proton Pump |
体外研究 |
Soraprazan (BYK61359) is a potent inhibitor of gastric H,K-ATPase,with an IC50 of 0.1μM when measured in ion-leaky vesicles in the presence of 1mM potassium.Soraprazan (BYK61359) also effectively inhibits dibutyryl cAMP-stimulated [14C]AP accumulation in isolated gastric glands with an IC50 of 0.19μM (0.09-0.40μM geometric mean from n=6 with 95% confidence limits). |
体内研究 |
Soraprazan (1-27μmol/kg;p.o.) shows rapid and consistent inhibition of acid secretion in dog. |
推荐实验方法(仅供参考)
激酶实验: |
[3H]Soraprazan binding studies are carried out at 20℃.In saturation experiments to determine the Kd value,ion-leaky gastric vesicles (0.01-0.02mg/mL) are resuspended in a buffer composed of 20mM Tris-HCl,pH 7.0,2mM MgCl2,and 2mM ATP (pH 7.0 by Tris) in the presence of increasing concentrations of [3H]soraprazan (0.1nM-1μM).Nonspecific binding is determined in the presence of a 100 fold excess of unlabeled soraprazan over the concentration range of [3H]soraprazan used.The enzyme suspension (1mL) is incubated at 20℃ for 30 min and rapidly filtered through a nitrocellulose membrane filter (0.45μM) prewet with a solution composed of 20mM Tris-HCl,pH 7.0,10% polyethylene glycol 3350 that is placed on top of a glass fiber filter.The membrane is ished five times with 2.5mL of a buffer composed of 20mM Tris-HCl,pH 7.0,and 10% polyethylene glycol 3350 to remove unbound inhibitor.The membrane is put into a 20-mL scintillation vial,dimethylacetamide (0.5mL) is added to dissolve the membrane,and 14mL of scintillation solvent is added and counted.Binding of [3H]soraprazan is determined by subtracting the nonspecific binding of [3H]soraprazan,obtained in the presence of the 100-fold excess of nonradioactive soraprazan,from the amounts of [3H]soraprazan bound to the membrane in the absence of the cold inhibitor. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )